Introduction: Neuroinflammation is involved in the pathophysiology of major depressive disorder. Sickness behavior such as sleep disorder, anhedonia, anorexia, and social withdrawal is observed as lipopolysaccharide (LPS)-induced depressive-like behaviors in mice. LPS stimulates PI3K-Akt signaling via TLR and regulates a variety of cellular processes, including cytokine and chemokine expression. Phospholipase C-related catalytically inactive protein (PRIP) is a signaling molecule to regulate phosphatidylinositol metabolism signaling. Here, we investigated LPS-induced anorexia in Prip-knockout (KO) mice. Materials and Methods: LPS (100 microgram/kg) or saline (as a control) was injected intraperitoneally into wild-type (WT) and Prip-KO mice that were pretreated with saline 24 h prior to LPS injection. Food intake was monitored during each 24 h before and after the LPS injection. Hypothalami were obtained from the LPS-or saline-treated mice. Primary microglial cells were prepared from neonatal mice treated with LPS (10 ng/mL) for 3h. The expression levels of protein and mRNA were estimated by western blot and quantitative PCR analyses, respectively. Result: Food intake in LPS-treated Prip-KO mice was less than WT mice. Compared with WT mice, interleukin (IL)-6 mRNA and phosphorylated STAT3 (P-STAT3) were increased in the Prip-KO hypothalamus, which was inversely correlated with the timedependent pattern of the food intake. Furthermore, the mRNA expression of IL-10, an anti-inflammatory cytokine, was evidently decreased in LPS-treated Prip-KO microglia. Discussion: The production of IL-6 and IL-10 is induced by LPSmediated activation of PI3K/Akt signaling. The IL-6-mediated STAT3 phosphorylation in the hypothalamus decreases food intake. Therefore, the upregulation of PI3K-Akt signaling in Prip-KO mice increased pro-inflammatory cytokine production with suppression of IL-10 production. This mediated the upregulation of IL-6 expression and STAT3 phosphorylation in hypothalamus, resulting in anorexia. These data indicate that PRIP regulates feeding behavior in neuro-inflammation via production of IL-10. 
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SEX DIFFERENCES IN AFFECTIVE DISORDERS IN ADULT RATS AFTER INFANTILE IMMUNE STIMULATION
Instituto Cajal, C.S.I.C, Madrid, Spain
Abstract It is known that an inflammatory challenge during the prenatal period results in permanent changes in glial cells and behavior in adulthood. However, it is unknown whether an inflammatory challenge during the infantile period may have permanent sex dimorphic effects in microglia and astrocytes in vivo, which in turn may be associated with sex differences in adult behavior. In this study we have evaluated whether postnatal injection of lipopolysaccharide (LPS; 250ug/kg, i.p. on postnatal day 14), induces depressive and anxiety-like behaviors, glial cell activation, pro-inflammatory cytokine (TNF alpha) secretion and sexually dimorphic responses in adulthood. Postnatal day 14 (P14) male and female rats received an intraperitoneal injection of LPS or PBS, Three months later, animals were tested in the open field (OF), the elevated plus maze (EPM) and the forced swimming test (FST) to assess the level of anxiety and depression. Hippocampal proinflammatory cytokine TNF alpha concentration and the number of astrocytes and microglia were estimated in the dentate gyrus, CA1 and CA3. Administration of LPS resulted in alterations in anxiety and depressive behaviors in male rats but not in female rats. LPS resulted in increased number of astrocytes in the hippocampus in both sexes, although the response was higher in females. Furthermore, LPS increased the number of microglia in the hippocampus, but only in females. These findings indicate that an immune challenge in infantile rats induces sex differences in affective behavior in adulthood, which may be the consequence of sex differences in the number of astrocytes and microglia in the hippocampus.
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Effect of bright and dim light on taste thresholds of sweet and salt: Replication study on Indian subjects 
Abstract
Purpose of the study: Ambient light affects serotonin throughput in the brain.The sweet taste threshold is governed by central serotonin levels as as it is significantly increased by paroxetine but not reboxetine (Heath et al 2006) . In a previous study, we showed that 10000 lux light, but not dim light,also decreases sweet thresholds in healthy volunteers (Srivastava et al 2013) . The present study is the replication of the UK study (latitude 52 0 ) in different climatic region (latitude 26 0 ). Methods: The study was cleared with institutional ethics committee. Healthy volunteers of either sex, without any past or present psychiatric disorder(s) were included in the study. In a cross-over design, sweet and salt taste perception were measured before and after 30 minutes of dim (<20 lux) and bright (10000 lux) light. The order of exposure to light phases was randomised across tests, with a 30-minute washout period in between the 2 light phases. Taste perception was tested by asking participants to report if they could perceive sweet or salt taste when presented with cotton buds dipped in various concentrations (100 to -1mMol) of the tastant, to the tip of their tongue. Results: Fourteen subjects (males =8) of mean age = 32.3 (s.d. 7.1) gave informed consent to participate. There were no significant differences seen in all 4 VAS scales or for taste pleasantness (F=1.891,ns) and intensity (F=.075, ns), or for taste thresholds for sweet [F(DFn, DFd) = .3138(6,432)] or salt [F(DFn, DFd) = 1.285(6,432)] modality for either bright or dim light phases.
Conclusions:
The results were different from the UK study. The possible reasons for the difference can be: 1. Ambient lightthis was markedly high in India (mean = 44000 lux) as compared to UK (mean = 17864 lux), and thus the artificial light source of 10000 lux would have much less impact on Indian subjects. 2. Ethnicity -in both studies the subjects were born and spent considerable time in their own respective country. 3. Cultural variations in the food consumed usually by the subjects in respective countries.
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Major depressive disorder and initial insulin hyposecretion in oral glucose tolerance test Methods: Twenty-five outpatients with DSM-IV MDD were recruited into the study along with 28 controls. A 5-hour OGTT using 75 g of glucose was employed to assess glucose regulation based on blood samples. Samples were drawn nine times and blood pressure, heart rate and body temperature were also measured at the same time.
Results: Patients with MDD had a higher impaired glucose tolerance (IGT) rate at 52% versus 32% among the controls. MDD patients exhibited significantly lower insulinogenic index (P = 0.043) and disposition index (P = 0.020) than controls. The areas under the curve for heart rate (P = 0.017) and body temperature (P = 0.024) during the OGTT were significantly higher in MDD than in the controls. Conclusion: MDD patients exhibited hyperglycemia, initial insulin hyposecretion, and sympathetic dominance during the OGTT resulting in IGT compared to controls. Abstract Background: Subanaesthetic doses of intravenous ketamine have been shown to elicit rapid reduction in depressive symptoms and severity of suicidal ideation (SI). However, the antidepressant properties of ketamine appear to be transient. Repeated ketamine infusions may prolong the antidepressant effect. The objective of this study was to determine whether ketamine could elicit decrease in SI even in patients who do not have a reduction in depressive symptoms with prolonged treatment.
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Ketamine Exerts a Prolonged Reduction in Suicidal Ideation Independent of its Antidepressant Effects
Methods: 19 patients with treatment-resistant major depressive disorder (MDD) completed a randomized controlled trial of ketamine. Patients received 7 intravenous ketamine infusions during the study, including a single infusion during the Phase 1 double-blind crossover with midazolam (used as an active placebo), and 6 ketamine infusions administered over a two-week period during Phase 2. The primary outcome measures were pre-and post-treatment changes in depressive symptoms (using the Montgomery-Asberg Depression Rating Scale [MADRS]) and suicidal ideation (using MADRS-SI scores).
Results: Patients with a 50% decrease in total MADRS scores from pre-to post-treatment were considered ketamine responders. Responders (n = 10) had a larger reduction in MADRS scores (62%) compared to nonresponders (n = 9; 17%) (p<0.001). Both groups had significant reductions in MADRS-SI scores (responders -1.9, p<0.001; nonresponders -1.6, p<0.001) and the difference in the magnitude of change in MADRS-SI scores between groups was not statistically significant (p=0.44).
Conclusions: Ketamine had a direct effect on lessening suicidal ideation even in patients who failed to show a reduction in depression severity with repeated infusions.
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Validation of the 
